Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul;201(1):12-13.
doi: 10.1111/cei.13452. Epub 2020 May 27.

Innate immunity in systemic sclerosis

Affiliations
Editorial

Innate immunity in systemic sclerosis

S O'Reilly. Clin Exp Immunol. 2020 Jul.
No abstract available

PubMed Disclaimer

References

    1. Fullard N, O’Reilly S. Role of innate immune system in systemic sclerosis. Semin Immunopathol 2015; 37:511‐517. - PubMed
    1. Dowson C, Simpson N, Duffy L, O’Reilly S. Innate immunity in systemic sclerosis. Curr Rheumatol Rep 2017; 19:2. - PubMed
    1. Ciechomska M, Huigens CA, Hügle T et al Toll‐ike receptor‐mediated, enhanced production of profibrotic TIMP‐1 in monocytes from patients with systemic sclerosis: role of serum factors. Ann Rheum Dis 2013; 72:1382. - PMC - PubMed
    1. Bhattacharyya S, Tamaki Z, Wang W et al FibronectinEDA promotes chronic cutaneous fibrosis through Toll‐like receptor signaling. Sci Transl Med 2020; 201:14–24. - PMC - PubMed
    1. Frasca L, Lande R. Toll‐like receptors in mediating the pathogenesis in systemic sclerosis. Clin Exp Immunol 2020. 10.1111/cei.13426. - DOI - PMC - PubMed

Publication types